Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in ...

Posts from this topic will be added to your daily email digest and your homepage feed. If you want to tweak what’s on your feed, you can make a post and ask. If you want to tweak what’s on your feed, ...

AI startup Anthropic's claim of automating COBOL modernization sent IBM's stock plummeting, wiping billions off its market value. The decades-old language, still powering critical systems, faces a ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

The EU is threatening to take action against the social media company. It could be the start of a global reckoning. Katie is a UK-based news reporter and features writer. Officially, she is CNET's ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

Meta on Wednesday debuted an AI feature called "Dear Algo" that lets Threads users personalize their content-recommendation algorithms. Threads users will be able to tell the Dear Algo tool what kinds ...

Today's job market prospects can be brutal, especially as the latest AI-driven tools and people analytics are reshaping the talent lifecycle. When an algorithm has the power to decide who deserves an ...

Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS using one of the services below. You've just tried to add this ...